Physician profile

Jessica Gerner

Family · Dyer, IN

NPI 1740834241

$1,938.14

in general payments reported to CMS, 2019-2025

34 companies · $753 in 2025

The $753 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).

See the full distribution for Family

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,711.72

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $254.92 2022-2025 Rybelsus, Ozempic, Wegovy
Lilly USA, LLC $228.26 2022-2025 Mounjaro, Zepbound, Jardiance
Abbvie INC. $206.86 2022-2025
Amgen INC. $163.14 2022-2025 Repatha, Otezla, Repatha
Pfizer INC. $135.96 2022-2025
Otsuka America Pharmaceutical, INC. $115.82 2023-2025 Rexulti, Nuedexta
Astellas Pharma US INC $92.00 2022-2025 Veozah
Astrazeneca Pharmaceuticals LP $80.96 2024-2025 Farxiga, Airsupra
Axsome Therapeutics, INC. $69.86 2023-2025 Auvelity
Exact Sciences Corporation $65.29 2024-2025 Cologuard Collection Kit
Phadia US INC. $58.41 2022-2025 Immunocap
Boehringer Ingelheim Pharmaceuticals, INC. $32.11 2023-2024 Tradjenta
Glaxosmithkline, LLC. $31.85 2025 Shingrix, Arexvy
Abbott Laboratories $29.76 2025 Eterna
Inspire Medical Systems, INC. $29.36 2025 Inspire
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Organon LLC $27.20 2025 Nexplanon
Sumitomo Pharma America, INC. $22.61 2025 Gemtesa
Vertos Medical, INC. $20.94 2024 Mild Device Kit
Alnylam Pharmaceuticals INC. $20.44 2024 Givlaari
Vertex Pharmaceuticals Incorporated $19.30 2025
Phathom Pharmaceuticals, INC. $18.88 2024 Voquezna
Optinose US, INC. $18.81 2024
Sanofi Pasteur INC. $18.40 2023
Hologic Sales and Service, LLC $18.39 2025 Aptima
Almatica Pharma LLC $18.34 2023 Gralise, Loreev Xr
Avanir Pharmaceuticals, INC. $17.89 2022
Indivior INC. $17.54 2025 Sublocade
Dexcom, INC. $16.86 2025 Dexcom G6 Transmitter
Biohaven Pharmaceutical Holding Company LTD. $16.81 2022
Edwards Lifesciences Corporation $15.48 2024 Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Exeltis, USA INC. $14.72 2023 Slynd
Amneal Pharmaceuticals LLC $14.53 2024 Unithroid
Vivaquant INC, Dba Rhythm Express $14.28 2025 Rhythm Express
Bayer Healthcare Pharmaceuticals INC. $12.16 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jessica Gerner

$1,938.14

in general payments reported 2019-2025

Years
2022-2025
Top company
Novo Nordisk INC
Context
The $753 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).

https://glasscript.com/doctor/10658810/jessica-gerner

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.